Cost of antimicrobial resistance in healthcare settings: A critical review

Liana R. Merz, Rebecca M. Guth, Victoria J. Fraser

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations


Antibiotic resistant bacteria are a significant problem of public health importance, and are responsible for substantial hospital morbidity, mortality and cost. Estimates of cost vary, however, depending on the organism of interest, the study design and other factors. Most previous cost studies focused on antibiotic resistance as it impacts healthcare facility costs. Differences in design and methods make comparisons between these studies difficult, and there are clear limitations in the methodology frequently used in these analyses. Significant improvement is needed in studies of the cost of antimicrobial resistance, including more rigorous design and analytical methods, to generate more reliable estimates of the real cost of antibiotic resistance. Collaboration with economic experts will aid in producing more accurate cost estimates that can be used to guide healthcare administration decisions and resource utilization.

Original languageEnglish
Title of host publicationAntimicrobial Resistance
Subtitle of host publicationBeyond the Breakpoint
EditorsJ. Todd Weber
Number of pages18
StatePublished - 2010

Publication series

NameIssues in Infectious Diseases
ISSN (Print)1660-1890
ISSN (Electronic)1662-3819


Dive into the research topics of 'Cost of antimicrobial resistance in healthcare settings: A critical review'. Together they form a unique fingerprint.

Cite this